All lobbying filings

SCHAERR JAFFE LLP

SCHAERR JAFFE LLP filed a Q4 report for CELLPHIRE THERAPEUTICS, INC. on January 20, 2026.

Lobbying for CELLPHIRE THERAPEUTICS, INC. · biotechnology company

All filings by SCHAERR JAFFE LLP · Everything CELLPHIRE THERAPEUTICS, INC. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Maryland

Official filing document

Government bodies contacted 1

Health & Human Services, Dept of (HHS)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Blood platelet technology and the Strategic National Stockpile

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.